Артериальная гипертензия у пожилых пациентов: особенности патогенеза и подходов к лечению. Место диуретиков

1. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 2007; 25: 1105–87.
2. Ong KL, Cheung BMY, Man YB et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49: 69–75.
3. Franklin SS, Jacobs MJ, Wong ND et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869–74.
4. Lloyd-Jones DM, Evans JC, Larson MG et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–9.
5. Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J 1985; 109: 581–5.
6. Pannier B, Brunel P, Aroussey WE et al. Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens 1989; 7: 127–32.
7. Garden JM, Gottdiener JS, Wong ND et al. Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 1997; 29: 1095–103.
8. Rutan GH, McDonald RH, Kuller LH. A historical perspective of systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol 1989; 42: 663–73.
9. Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology clinical course of hypertension. Am J Med 1991; 90: 7S–12.
10. Luc M.A.B. Van Bortel, Harry AJ. Struijker-Boudier; Michel E. Safar Pulse Pressure, Arterial Stiffness, and Drug Treatment of Hypertension Hypertension 2001; 38: 914.
11. Izzo J. Stagnation and the Critical Need for Hypertension Subtyping. Clin Hypertens 2008; 10 (3): 174–5.
12. Franklin SS, Gustin W, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–15.
13. Franklin SS, Khan SA, Wong ND et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354–60.
14. Franklin SS, Pio JR, Wong ND et al. Predictors of new-onset diastolic and systolic hypertension. The Framingham Heart Study. Circulation 2005; 111: 1121–7.
15. Franklin S. Hypertension in Older People: Part 2. J Clin Hypertens 2006; 8: 521–5.
16. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304 (6824): 405–12.
17. Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1 (8442): 1349–54.
18. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.
19. Dahlof B, Hansson L, Lindholm LH et al. Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992. Clin Exp Hypertens 1993; 15 (6): 925–39.
20. Hansson L, Lindholm LH, Ekbom T et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354 (9192): 1751–6.
21. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertension 2009; 27: 2121–58.
22. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
23. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 843–53.
24. Beckett NS, Peters R, Fletcher AE et al. HYVET Study Group Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358 (18): 1887–98.
25. Gueyffier F, Bulpitt C, Boissel J-P et al for the INDANA Group Antihypertensive drugs in the very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 1999; 353: 793–6.
26. Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1 (8442): 1349–54.
27. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.
28. Dahlof B, Hansson L, Lindholm LH et al. Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992. Clin Exp Hypertens 1993; 15 (6): 925–39.
29. PROGESS Collaborative Study Group. Randomised trial period of perindopril-based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358: 1033–41.
30. Gosse Ph, Sheridan D, Zannad F et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE Study. J Hypertension 2000; 18: 1465–75.
31. Marre M, Garcia-Puig J, Kokot F et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study. J Hypertension 2004; 22: 1613–22.
32. Marre M, Garcia-Puig J, kokot F et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertens 2007; 20: 90–7.
33. Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155–65.
34. Results of the pilot study for the Hypertension in the Very Elderly Trial. C.Bulpitt, N.Beckett, J.Cooke, D.Dumitrascu, B.Gil-Extremera, C.Nachdev, M.Nunes, R.Peters, J.Staessen, L.Thijs, on behalf of the Hypertension in the Very Elderly Trial (HYVET) working group. J Hypertens 2003; 21: 2409–17.

А.О.Конради